Source comparison
PT-141 Dosage for Hypoactive Sexual Desire: Formulation and Preparation Comparison
FDA-approved autoinjector (Vyleesi) 1.75mg fixed ~100% (subcutaneous) 40% at labeled dose No. Pre-filled single-use pen Convenient but expensive ($850–$1,100 per dose); no titration flexibility Compounded lyophilized powder (503B pharmacy) 0.5–2mg customizable
This comparison does not assign a generated winner or score.
- FDA-approved autoinjector (Vyleesi)
- 1.75mg fixed
- ~100% (subcutaneous)
- 40% at labeled dose
- No. Pre-filled single-use pen
- Convenient but expensive ($850–$1,100 per dose); no titration flexibility
- Compounded lyophilized powder (503B pharmacy)
- 0.5–2mg customizable
- 95–100% if reconstituted correctly
- Variable. Dose-dependent
- Yes. Requires bacteriostatic water and aseptic technique
- Cost-effective ($40–$80 per dose); allows titration; requires preparation skill
- Nasal spray formulation (investigational)
- 5–10mg intranasal
- 3–8% (poor mucosal absorption)
- Low (bypasses MC4R-mediated nausea in some patients)
- No
- Not commercially available in 2026; lower efficacy than subcutaneous route